MACQUARIE GROUP LTD - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$632,000
-22.5%
20,0000.0%0.00%0.0%
Q2 2023$816,000
+9.5%
20,0000.0%0.00%0.0%
Q1 2023$745,000
+6.7%
20,0000.0%0.00%0.0%
Q4 2022$698,000
-41.3%
20,000
-2.3%
0.00%0.0%
Q3 2022$1,190,000
+8.1%
20,479
-3.7%
0.00%0.0%
Q2 2022$1,101,000
-28.7%
21,2720.0%0.00%0.0%
Q1 2022$1,545,000
-38.6%
21,2720.0%0.00%
-50.0%
Q4 2021$2,515,000
-13.0%
21,272
-1.3%
0.00%0.0%
Q3 2021$2,892,000
-14.2%
21,559
+3.5%
0.00%
-33.3%
Q2 2021$3,372,000
+96.7%
20,829
-2.5%
0.00%
+50.0%
Q1 2021$1,714,000
+44.8%
21,357
-1.9%
0.00%0.0%
Q4 2020$1,184,000
+173.4%
21,7730.0%0.00%
+100.0%
Q3 2020$433,000
-5.3%
21,7730.0%0.00%0.0%
Q2 2020$457,000
+11325.0%
21,773
+7157.7%
0.00%
Q4 2018$4,000
+33.3%
300
+200.0%
0.00%
Q3 2018$3,000
-97.0%
100
-97.3%
0.00%
Q2 2018$101,0003,7000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders